Yeast growth selection system for detecting activity and inhibition of dimerization-dependent receptor tyrosine

Tea Gunde1, Alcide Barberis

  • 1ESBATech AG, Zürich-Schlieren, Switzerland.

Biotechniques
|October 21, 2005
PubMed

Insights

We developed a novel yeast assay to monitor receptor tyrosine kinase (RTK) activity, specifically the epidermal growth factor receptor (EGFR). This system enables high-throughput screening for new cancer drug inhibitors.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Oncology

Background:

  • Receptor tyrosine kinases (RTKs) regulate crucial cellular functions like proliferation and survival.
  • Aberrant RTK signaling is implicated in human cancer development and progression.

Purpose of the Study:

  • To establish a heterologous yeast-based assay for monitoring RTK activity.
  • To demonstrate the utility of this assay for screening RTK inhibitors.

Main Methods:

  • Utilized a Ras-recruitment system in a temperature-sensitive yeast strain (cdc25-2).
  • Reconstituted the epidermal growth factor receptor (EGFR) signaling pathway in yeast.
  • Assessed EGFR activity by monitoring yeast growth rescue at nonpermissive temperatures.

Main Results:

  • Co-expression of a dimerizing EGFR variant with active Ras rescued yeast growth.
  • Yeast growth rate correlated with EGFR kinase activity, validated by kinase-defective mutants and inhibitors.
  • Demonstrated the assay's ability to detect functional RTK activity.

Conclusions:

  • The developed yeast assay provides a robust platform for studying mammalian RTK signaling.
  • This system is suitable for high-throughput screening of cell-permeable RTK inhibitors for cancer therapy.